Overview

Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Investigator has since decided not to pursue this protocol further. No patients were enrolled. This study is to determine the maximum tolerated dose of external beam radiation to the para-aortic lymph nodes using intensity modulated radiation therapy (IMRT). This protocol will test the hypothesis that the use of IMRT and amifostine will decrease GI toxicity and therefore allow the radiation dose to the para-aortic lymph nodes to be safely escalated.
Phase:
Phase 1
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
MedImmune LLC
Treatments:
Amifostine
Cisplatin